XML 47 R36.htm IDEA: XBRL DOCUMENT
v3.23.1

Commitments and Contingencies - Additional information (Details) - USD ($) |  | 3 Months Ended | 12 Months Ended
--- | --- | --- | ---
Mar. 01, 2023 | Mar. 31, 2023 | Dec. 31, 2021
Commitments and Contingencies |  |  |
Financing liability |  | $ 1,928,000 |
Accrued settlement |  | 200,000 |
Penn License Agreement | Penn |  |  |
Commitments and Contingencies |  |  |
Annual payments to be made |  | 25,000 | $ 10,000
Additional milestone payments for first CAR-M product |  | 1,700,000 |
Penn License Agreement | Penn | Maximum |  |  |
Commitments and Contingencies |  |  |
Milestone payments |  | 10,900,000 |
Additional milestone payments |  | 30,000,000.0 |
Novartis Agreement |  |  |
Commitments and Contingencies |  |  |
Agreement term | 5 years |  |
Renewal term | 1 year |  |
Amount payable per calendar year for reserved capacity | $ 1,000,000.0 |  |
Termination fee payable | $ 4,000,000.0 |  |
Lab equipment |  |  |
Commitments and Contingencies |  |  |
Financing liability |  | $ 2,700,000 |

X
- Definition Additional amount required to be paid in development and regulatory milestone payments for the first CAR-M product directed to mesothelin. + References No definition available. + Details
Name: | carm_AdditionalMilestonePaymentsForFirstCarMProduct
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of additional milestone payments required to be paid per product in commercial milestones. + References No definition available. + Details
Name: | carm_AdditionalMilestonePaymentsRequiredToBePaid
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The period of agreement. + References No definition available. + Details
Name: | carm_AgreementTerm
Namespace Prefix: | carm_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount payable per calendar year for reserved capacity. + References No definition available. + Details
Name: | carm_AmountPayablePerCalendarYearForReservedCapacity
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount required to pay per product in development upon the achievement of certain clinical, regulatory and commercial milestone events. + References No definition available. + Details
Name: | carm_AmountPayableUponAchievementOfCertainClinicalRegulatoryAndCommercialMilestoneEvents
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of annual payments required to be paid. + References No definition available. + Details
Name: | carm_CommitmentsAnnualPaymentsRequiredToBePaid
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The renewal term of agreement. + References No definition available. + Details
Name: | carm_RenewalTerm
Namespace Prefix: | carm_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of termination fee payable. + References No definition available. + Details
Name: | carm_TerminationFeePayable
Namespace Prefix: | carm_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Present value of lessee's discounted obligation for lease payments from finance lease. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 842 -SubTopic 20 -Section 45 -Paragraph 1 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977 + Details
Name: | us-gaap_FinanceLeaseLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of loss contingency liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 10 -URI https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349 + Details
Name: | us-gaap_LossContingencyAccrualAtCarryingValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=carm_PennLicenseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=carm_TrusteesOfUniversityOfPennsylvaniaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=carm_ManufacturingAndSupplyAgreementWithNovartisPharmaceuticalsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_LeaseContractualTermAxis=carm_LabEquipmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |